Table 3.
Association of expression profile of ESC-related markers in precancerous lesions and OSCCs
| Oct4 positive (%) | Sox2 positive (%) | Both high expression (%) | Both low expression or negative (%) | |
|---|---|---|---|---|
| Precancerous lesions (20 cases) | 14 (70) | 18 (90) | 12 (60) | 1 (5) |
| Primary sites of OSCCs (116 cases) | 70 (60) | 74 (64) | 38 (33)a | 11 (9)aa |
| Paired OSCCs (46 cases) | ||||
| Primary sites | 26 (57)* | 46 (100)# | 19 (41) | 0 (0) |
| Metastatic sites | 22 (48) | 30 (65) | 8 (17)b | 14 (30)bb |
| Nodal-negative OSCCs (70 cases) | 44 (63)** | 28 (40)## | 19 (27) | 11 (16) |
*
p>0.05;
**
p>0.05;
#
p<0.05;
##
p<0.05;
a
p<0.05;
aa
p<0.05;
b
p<0.05.
bb
p<0.05.